Microarray analysis in Alzheimer's disease and normal aging

IUBMB Life
Roberta RicciarelliMassimo Tabaton

Abstract

The purpose of this study was to investigate gene expression in Alzheimer's disease (AD), the most common form of senile dementia. We utilized the microarray technology to simultaneously compare the expression profile of 12,000 human genes in cerebral cortex of AD and normal aging. To identify gene expression related to neurodegeneration, beside the presence of amyloid deposition, we used control brains with abundant amyloid plaques, derived from cognitively normal elderly subjects. The microarray analysis indicated that 314 genes were differentially expressed in AD cerebral cortex, with differences greater than 5 folds in 25 genes. RT-PCR performed on a selected group of genes confirmed the increased expression of the interferon-induced protein 3 in AD brain. This protein, which is highly inducible by both type I and type II interferons, was not previously associated with the neurodegenerative disease.

Citations

Apr 14, 2009·Current Atherosclerosis Reports·Myriam Fornage
Sep 18, 2009·Neurotoxicity Research·Amee J GeorgeQiao-Xin Li
Jul 4, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Stephen D GinsbergElliott J Mufson
Mar 1, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gwenn S SmithJovier D Evans
Jun 9, 2006·The New England Journal of Medicine·John Quackenbush
Oct 31, 2012·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Andras Bilkei-Gorzo
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Yosuke NagasakaCaroline Graff
Dec 4, 2015·International Journal of Molecular Sciences·Daisuke Ibi, Kiyofumi Yamada
Aug 14, 2012·Free Radical Biology & Medicine·Mahesh RamamoorthyVilhelm A Bohr
Sep 3, 2009·Biochemical and Biophysical Research Communications·Ira L GoldknopfKaterina Markopoulou
Sep 12, 2007·Neurobiology of Aging·Vahram HaroutunianJames Schmeidler
Oct 27, 2005·Ageing Research Reviews·James E Galvin, Stephen D Ginsberg
Aug 23, 2005·Neurobiology of Aging·Ivona BrasnjevicChristoph Schmitz
Jun 24, 2010·Neurobiology of Aging·Dimitrios AvramopoulosSusan Bassett
Sep 15, 2014·European Journal of Pharmacology·Akira NakajimaKiyofumi Yamada
Dec 3, 2014·Neurobiology of Aging·Wail M HassanChristopher D Link
Feb 11, 2015·Chinese Journal of Natural Medicines·Shi-Kai YanWei-Dong Zhang
Dec 26, 2008·Stroke; a Journal of Cerebral Circulation·Julie E SimpsonUNKNOWN Medical Research Council Cognitive Function and Ageing Study Neuropathology Group
Mar 3, 2018·Psychopharmacology·Laura B FergusonRoy Dayne Mayfield
Aug 18, 2017·Proteomics·Virginia CorreaniM Eugenia Schininà
Jul 15, 2015·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Andrew LiParamita Chakrabarty
May 23, 2020·International Journal of Molecular Sciences·Juan Luis Fernández-MartínezAndrzej Kloczkowski
Apr 7, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Paramita ChakrabartyPritam Das
Nov 12, 2015·Biochemistry. Biokhimii︠a︡·A A NizhnikovS G Inge-Vechtomov
Jun 28, 2017·Proceedings of the National Academy of Sciences of the United States of America·Rishika KundraMichele Vendruscolo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.